Sun Pharma Advanced Research Company Limited

NSE:SPARC.NS

207.44 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42011 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 56.7-1,571.3081,553.3-3,66113.1-4,024.7295.8-41.921.9-128.812.242-829.9582.5-157.493.045-257.78-89.53.523-563.19.4-2,109.2563.496-1,433.62.3-1,0892.03-709.316.4-798.602635.839-1,870.41,870.3-127.48540.001-67.767.7-173.441106.342-75.975.9-130.5530.095-459.763.1-1,036.29667.23765.05
Short Term Investments 43,142.616187,3223,772.18,049.4584,060.583.875.7257.6116.6491,659.8265314.864.252515.4283.517984.9091,126.2555.14,218.5122,105.762,867.21,4772,1781,086.8791,418.6692.91,597.20495.5393,740.80.1254.970135.40346.8820151.80261.10665.002919.4396.62,072.592969.0590
Cash and Short Term Investments 60.71,571.3081,571.33,6613,785.24,024.7294,066.341.997.6128.8128.891829.9847.5157.4157.297257.7291.589.588.432563.1564.52,109.2562,109.2561,433.61,479.31,0891,088.909709.3709.3798.602731.3781,870.41,870.4127.48540.00167.767.7173.441106.34275.975.9130.55365.097459.7459.71,036.2961,036.29665.05
Net Receivables 136.10157.50318.80374.18019.1450280.70238.40176.4370147.60160.4630199.60101.67303600175.5940137.20389.0020243.8091.5960407.70198.8680422.30279.9890232.60250.5640
Inventory 0014.792000-41.680331.755010.7760007.96100024.8200049.38405.9020.40708.6030.66800066.51700016.1820377.5036.7240621.5039.9750
Other Current Assets 708.709650321.70150.70285.50273.40301.10264.20241.30583.4480322.70279.0670293.60441.0860436.603.965035.505.74702.802.786034.302.78602.902.7861.085
Total Current Assets 905.51,571.3082,693.83,6614,425.74,024.7294,549.541.9734128.8711.523829.91,387157.4631.113257.7682.989.5671.88563.11,0942,109.2562,573.821,433.62,138.81,0891,752.247709.31,291.7798.6021,585.8031,870.42,597.2127.485665.9167.7792.8173.441629.34775.9910130.5531,101.165459.71,316.71,036.2961,390.135182.174
Non-Current Assets:
Property, Plant & Equipment, Net 1,046.501,086.101,085.501,072.801,035.30951.17809340951.07601,044.601,065.5840973.70811.10782.30547.7670709.90706.2550714.60708.2940687.90668.1520679.80652.4920653.20657.123650.697
Goodwill 000000000000000000000000000000000000000000000000
Intangible Assets 426.40427.20254.10254.70230.60231.157024.406.8507.70293.7305.305.7070202.259000000000000000000000
Goodwill and Intangible Assets 426.40427.20254.10254.70230.60231.157024.406.8507.70293.7305.305.7070202.259000000000000000000000
Long Term Investments 256.10254.90-3,518.30-2,286.40172.90115.1510-260.603.9860000000000000-692.60000000000000000000
Tax Assets 7.1012.604,422.304,686.50747.40785.81908690-3.986000000000000000000000000000000000
Other Non-Current Assets 566.5-1,571.308675.8-3,6614.8-4,024.72924.1-41.93.5-128.86-829.94-157.4707.859-257.7764.2-89.5694.438-563.1647.2-2,109.256594.124-1,433.6560.3-1,089785.829-709.31,148.2-798.602448.315-1,870.4271.7-127.485252.397-67.7206.4-173.441129.198-75.983.6-130.55381.733-459.746.5-1,036.29642.66723.39
Total Non-Current Assets 2,302.6-1,571.3082,456.6-3,6612,248.4-4,024.7293,751.7-41.92,189.7-128.82,089.305-829.91,570.8-157.41,665.785-257.71,816.5-89.52,053.752-563.11,626.2-2,109.2561,410.931-1,433.61,344.6-1,0891,335.855-709.31,165.5-798.6021,154.57-1,870.4986.3-127.485960.691-67.7894.3-173.441797.35-75.9763.4-130.553734.225-459.7699.7-1,036.296699.79674.087
Total Assets 3,208.105,150.406,674.108,301.202,923.702,800.82802,957.802,296.89802,499.402,725.63202,720.203,984.75103,483.403,088.10202,457.202,740.37303,583.501,626.60101,687.101,426.69701,673.401,835.3902,016.402,089.925856.261
Liabilities & Equity:
Current Liabilities:
Account Payables 1,403.301,422.901,679.101,482.601,209.40721.8710652.40990.63301,271.201,588.43401,084.30829.31301,081.401,024.8490839.80944.52907700581.51105070270.1070267.80297.4630226.80127.932162.119
Short Term Debt 923.80504.9031.3030.501,849.90767.76801,14201,196.66301,008.90619.66202005.4520006.4920009.56200.50530.2140164.409.40700.1013.6890537.40765.107625.799
Tax Payables 0016.5000000000000000000000000000000000000000000000
Deferred Revenue 0016.50313.50182.20126.70167.0670187.5097.9770104.1082.049063.8059.83100085.155000126.024036.40136.50708.9091.84408076.629011047.350
Other Current Liabilities 462.70706.20101.7094.10103.3057.583045.9048.244036.4063.409029.2055.84096.5044.602014200.1520139.4019.121014800.12064.600.116074.801.999662.124
Total Current Liabilities 2,789.802,650.502,125.601,789.403,289.301,714.28902,027.802,333.51702,420.602,353.55401,197.30950.43601,177.901,161.0980981.801,080.2670946.301,267.3530828.30371.4780340.50387.89708500942.3881,450.042
Non-Current Liabilities:
Long Term Debt 00106.60110.80126.2076.9024.3690408.501,167.151050.4063.783071.1010.905010.9016.357016.4021.809021.8027.261027.3032.714032.7038.166038.2043.61857.42
Deferred Revenue Non-Current 001,034.9430001,176.473000668.45000392.425000392.42500000000000000000000000000000
Deferred Tax Liabilities Non-Current 00-1,034.943000-1,095.073000-586.937000-306.079000000000000000000000000000000000
Other Non-Current Liabilities 1,192.1-1,257.5541,135.801,120.901,176.50744.30668.40474.30392.40495.80102.253058.8061.053063.8063.404044.1041.819032.9032.96026.5024.519019.1016.34021019.61314.885
Total Non-Current Liabilities 1,192.1-1,257.5541,242.401,231.701,384.10821.20774.2820882.801,645.8970546.20558.4610129.9071.958074.7079.761060.5063.628054.7060.221053.8057.233051.8054.506059.2063.23172.305
Total Liabilities 3,981.9-1,257.5543,892.903,357.303,173.504,110.502,488.57102,910.603,979.41402,966.802,912.01501,327.201,022.39401,252.601,240.85901,042.301,143.89501,00101,327.5740882.10428.7110392.30442.4030909.201,005.6191,522.347
Equity:
Preferred Stock 0019,448.565000000000000000000000004,152.656000000000000000000000
Common Stock 324.50324.50324.50324.50271.90271.8870263.50262.0560262.10262.0560262.10262.05602560250.9440246.90246.9040246.90236.6970236.70236.6830236.70236.680236.70236.599207.116
Retained Earnings 00-19,788.399000-15,918.134000-13,705.838000-11,688.848000-10,192.715000-7,043.975000-5,069.323000-3,432.466000-2,229.793000-1,529.873000-1,134.673000-1,437.9150
Accumulated Other Comprehensive Income/Loss 01,257.554339.8343,316.82,992.35,127.751339.766-1,186.8-1,458.7312.32,342.59747.2-216.3-1,682.59,666.566-467.4-729.5-186.4-314.6381,3931,130.92,962.357-02,230.81,974.81,847.2916.6671,414.91,1681,596.47802,582.52,335.6318.02418.997805568.3997.98601,281.11,044.41,392.98701,107.2870.51,084.30600
Other Total Stockholders Equity -1,098.3093300020,381.5680-0011,403.61100077.7100010,058.9140009,744.2760001,596.2990004,782.040002,273.1260002,291.1760002,290.980002,285.622-873.202
Total Shareholders Equity -773.81,257.5541,257.53,316.83,316.85,127.7515,127.7-1,186.8-1,186.8312.3312.25747.247.2-1,682.5-1,682.516-467.4-467.4-186.4-186.3831,3931,3932,962.3572,962.3572,230.82,230.81,847.21,847.2431,414.91,414.91,596.4781,596.4782,582.52,582.5318.024299.027805805997.986997.9861,281.11,281.11,392.9871,392.9871,107.21,107.21,084.3061,084.306-666.086
Total Equity -773.81,257.5541,257.53,316.83,316.85,127.7515,127.7-1,186.8-1,186.8312.3312.25747.247.2-1,682.5-1,682.516-467.4-467.4-186.4-186.3831,3931,3932,962.3572,962.3572,230.82,230.81,847.21,847.2431,414.91,414.91,596.4781,596.4782,582.52,582.5318.024299.027805805997.986997.9861,281.11,281.11,392.9871,392.9871,107.21,107.21,084.3061,084.306-666.086
Total Liabilities & Shareholders Equity 3,208.11,257.5545,150.43,316.86,674.15,127.7518,301.2-1,186.82,923.7312.32,800.82847.22,957.8-1,682.52,296.898-467.42,499.4-186.42,725.6321,3932,720.22,962.3573,984.7512,230.83,483.41,847.23,088.1021,414.92,457.21,596.4782,740.3732,582.53,583.5318.0241,626.6018051,687.1997.9861,426.6971,281.11,673.41,392.9871,835.391,107.22,016.41,084.3062,089.925856.261